Article Details
Retrieved on: 2021-04-01 12:38:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Seattle Genetics Inc., Takeda Pharmaceuticals Co. ... with its maytansinoid-based targeted antibody payload (TAP) technology, produced Kadcyla with ...
Article found on: bisouv.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here